Allianz Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-191,100
| Closed | -$1.66M | – | 1704 |
|
|
2024
Q1 | $1.66M | Buy |
+191,100
| New | +$1.66M | ﹤0.01% | 1105 |
|
|
2023
Q3 | – | Sell |
-33,079
| Closed | -$411K | – | 1707 |
|
|
2023
Q2 | $411K | Sell |
33,079
-36,602
| -53% | -$455K | ﹤0.01% | 1349 |
|
|
2023
Q1 | $976K | Buy |
+69,681
| New | +$976K | ﹤0.01% | 1275 |
|
|
2022
Q3 | – | Sell |
-64,305
| Closed | -$1.83M | – | 1587 |
|
|
2022
Q2 | $1.83M | Buy |
64,305
+23,677
| +58% | +$673K | ﹤0.01% | 1321 |
|
|
2022
Q1 | $1.43M | Sell |
40,628
-17,661
| -30% | -$623K | ﹤0.01% | 1458 |
|
|
2021
Q4 | $2.44M | Buy |
58,289
+22,241
| +62% | +$932K | ﹤0.01% | 1342 |
|
|
2021
Q3 | $1.77M | Sell |
36,048
-7,572
| -17% | -$372K | ﹤0.01% | 1406 |
|
|
2021
Q2 | $1.82M | Sell |
43,620
-671,187
| -94% | -$28M | ﹤0.01% | 1320 |
|
|
2021
Q1 | $25.5M | Sell |
714,807
-401,543
| -36% | -$14.3M | 0.02% | 520 |
|
|
2020
Q4 | $31.3M | Buy |
+1,116,350
| New | +$31.3M | 0.03% | 469 |
|